Skip to main content
OpenTrials

Clinical trial condition

Neuroectodermal Tumors, Primitive, Peripheral

Explore clinical trials studying Neuroectodermal Tumors, Primitive, Peripheral. Study availability and eligibility vary by location and protocol.

503 public trials 99 recruiting studies
Refine in advanced search Browse all conditions

Neuroectodermal Tumors, Primitive, Peripheral trial results

Recruiting

Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed High Risk Neuroblastoma

NCT06172296

Conditions
Ganglioneuroblastoma, Ganglioneuroblastoma, Nodular, Neoplasms, +9 more
Locations
  • Children's Hospital of Alabama Birmingham, Alabama, United States
  • USA Health Strada Patient Care Center Mobile, Alabama, United States
  • Banner Children's at Desert Mesa, Arizona, United States
  • Phoenix Childrens Hospital Phoenix, Arizona, United States
View all 179 locations
View Trial Details
Recruiting

Naxitamab Added to Induction for Newly Diagnosed High-Risk Neuroblastoma

NCT05489887

Conditions
Neoplasms, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, +7 more
Locations
  • University of Alabama/Children's of Alabama Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • UCSF Benioff Children's Hospital Oakland Oakland, California, United States
  • Rady Children's Hospital San Diego, California, United States
View all 26 locations
View Trial Details
Recruiting

Eflornithine (DFMO) and AMXT 1501 for Neuroblastoma, CNS Tumors, and Sarcomas

NCT06465199

Conditions
Atypical Teratoid/Rhabdoid Tumor, Brain Diseases, Brain Neoplasms, +30 more
Locations
  • University of Alabama/Children's of Alabama Birmingham, Alabama, United States
  • Arkansas Children's Hospital Little Rock, Arkansas, United States
  • Connecticut Children's Hospital Hartford, Connecticut, United States
  • Nicklaus Children's Hospital Miami, Florida, United States
View all 14 locations
View Trial Details
Recruiting

SPEARHEAD-3 Pediatric Study

NCT05642455

Conditions
Fibrosarcoma, Malignant Peripheral Nerve Sheath Tumor (MPNST), Neoplasms, +26 more
Locations
  • Stanford University Palo Alto, California, United States
  • National Institutes of Health Bethesda, Maryland, United States
  • Dana Farber Cancer Institute Boston, Massachusetts, United States
  • Washington University St Louis, Missouri, United States
View Trial Details

Related conditions